Mechanisms of disease: Mechanisms of muscle wasting: The role of the ubiquitin-proteasome pathway

New England Journal of Medicine

Volumn 335, Issue 25, 1996, Pages 1897-1905

  Mitch, William E ^a,c   Goldberg, Alfred L ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; UBIQUITIN; CYSTEINE PROTEINASE; MULTIENZYME COMPLEX; MUSCLE PROTEIN; PROTEIN;

CANCER; CATABOLISM; DISEASE ASSOCIATION; MUSCLE ATROPHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; REGULATORY MECHANISM; REVIEW; HUMAN; LYSOSOME; METABOLISM; MUSCLE; MUSCLE DISEASE; WASTING SYNDROME;

CYSTEINE ENDOPEPTIDASES; HUMANS; LYSOSOMES; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; MUSCLES; MUSCULAR DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; UBIQUITINS; WASTING SYNDROME;

EID: 0030593939     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199612193352507     Document Type: Review

References (70)

1. Young VR. Some metabolic and nutritional considerations of dietary protein restriction. In: Mitch WE, ed. The progressive nature of renal disease. Vol. 14 of Contemporary issues in nephrology. New York: Churchill Livingstone, 1986:263-83.
2. Kaysen GA, Schoenfeld PY. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984;25:107-14.
3. Waldmann TA, Blaese RM, Strober W. Physiological factors controlling immunoglobulin metabolism. In: Rothschild MA, Waldmann TA, eds. Plasma protein metabolism: regulation of synthesis, distribution, and degradation. New York: Academic Press, 1970:269-86.
4. Cohn SH, Vartsky D, Yasumura S, Vaswani AN, Ellis KJ. Indexes of body cell mass: nitrogen versus potassium. Am J Physiol 1983;244:E305-E310.
5. Tawa NE, Goldberg AL. Protein and amino acid metabolism in muscle. In: Engle AG, Franzini -Armstrong C, eds. Myology: basic and clinical. 2nd ed. New York: McGraw-Hill, 1994:683-707.
6. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 1994;78:773-85.
7. Chen ZJ, Hagler J, Palombella VJ, et al. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 1995;9:1586-97.
8. Fagan JM, Waxman L, Goldberg AL. Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin. J Biol Chem 1986;261:5705-13.
9. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 1995;83:129-35.
10. Ward CL, Omura S, Kopito RR. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 1995;83:121-7.
11. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules. Cell 1994;78:761-71.
12. Goldberg AL, Gaczynska M, Grant E, Michalek M, Rock KL. The functions of the proteasome in antigen presentation. In: Cold Spring Harbor Symposia on quantitative biology. Vol. 60. Protein kinases: the dynamics of protein trafficking and stability. Plainview, N.Y.: Cold Spring Harbor Laboratory Press, 1995:479-90.
13. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996;65:801-47.
14. Lowell BB, Ruderman NB, Goodman MN. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J 1986;234:237-40.
15. Hershko A, Ciechanover A. The ubiquitin system for protein degradation. Annu Rev Biochem 1992;61:761-807.
16. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994;79:13-21.
17. Goldberg AL, Ross S, Adams J. New insights into proteasome function: from archaebacteria to drug development. Chem Biol 1995;2:503-8.
18. Rechsteiner M, Hoffman L, Dubiel W. The multicatalytic and 26 S proteases. J Biol Chem 1993;268:6065-8.
19. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495-505.
20. Lowe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R. Crystal structure of the 20S proteasome from the archacon T. acidophilum at 3.4 A resolution. Science 1995;268:533-9.
21. Seemuller E, Lupas A, Stock D, Lowe J, Huber R, Baumeister W. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 1995;268:579-82.
22. Zamir O, Hasselgren PO, Kunkel SL, Frederick J, Higashiguchi T, Fischer JE. Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 1992;127:170-4.
23. Vinitsky A, Cardozo C, Sepp-Lorenzino L, Michaud C, Orlowski M. Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes. J Biol Chem 1994;269:29860-6.
24. Chu-Ping M, Slaughter CA, DeMartino GN. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem 1992;267:10515-23.
25. Chu-Ping M, Vu JH, Proske RI, Slaughter CA, DeMartino GN. Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome. J Biol Chem 1994;269:3539-47.
26. Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 1993;264:E668-E676.
27. Mitch WE, Medina R, Greiber S, et al. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 1994;93: 2127-33.
28. Price SR, Bailey JL, Wang X, et al. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome pathway by a mechanism including gene transcription. J Clin Invest 1996;98:1703-8.
29. Wing SS, Haas AL, Goldberg AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem J 1995;307:639-45.
30. Medina R, Wing SS, Goldberg AL. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 1995;307:631-7.
31. Price SR, England BK, Bailey JL, Van Vreede K, Mitch WE. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol 1994;267:C955-C960.
32. Medina R, Wing SS, Haas A, Goldberg AL. Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. Biomed Biochim Acta 1991;50:347-56.
33. May RC, Kelly RA, Mitch WE. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest 1986;77:614-21.
34. Reaich D, Grewal M, Price SR, et al. Catabolism in acute renal failure (ARF): evidence for stimulation of the ubiquitin-proteasome system and activation of branched-chain α-ketoacid dehydrogenase (BCKAD). J Am Soc Nephrol 1994;5:953. abstract.
35. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. J Clin Invest 1996;97:1447-53.
36. Clark AS, Mitch WE. Muscle protein turnover and glucose uptake in acutely uremic rats: effects of insulin and the duration of renal insufficiency. J Clin Invest 1983;72:836-45.
37. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia: influence of metabolic acidosis. J Clin Invest 1987;79:1099-103.
38. Clowes GHA Jr, George BC, Villee CA Jr, Saravis CA. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med 1983;308:545-52.
39. Hasselgren PO, James JH, Benson DW, et al. Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin. Metabolism 1989;38:634-40.
40. Hasselgren PO, Talamini M, James JH, Fischer JE. Protein metabolism in different types of skeletal muscle during early and late sepsis in rats. Arch Surg 1986;121:918-23.
41. Tiao G, Fagan JM, Samuels N, et al. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest 1994;94:2255-64.
42. Clowes GHA Jr, O'Donnell TF, Blackburn GL, Maki TN. Energy metabolism and proteolysis in traumatized and septic man. Surg Clin North Am 1976;56:1169-84.
43. Mansoor O, Beaufrere B, Boirie Y, et al. Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci USA 1996;93:2714-8.
44. Clark AS, Kelly RA, Mitch WE. Systemic response to thermal injury in rats: accelerared protein degradation und altered glucose utilization in muscle. J Clin Invest 1984;74:888-97.
45. Fang CH, Tiao G, James H, Ogle C, Fischer IF, Hasselgren PO. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J Am Coll Surg 1995;180:161-70.
46. Lawson DH, Richmond A, Nixon DW, Rudman D. Metabolic approaches to cancer cachexia. Annu Rev Nutr 1982;2:227-301.
47. Baracos VE, DeVivo C, Hoyle DHR, Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle or cachectic rats hearing a hepatoma. Am J Physiol 1995;268:E996-E1006.
48. Temparis SM, Asensi M, Taillandier D, et al. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res 1994;54:5568-73.
49. Tawa NE Jr, Odessey R, Goldberg AL. Peptide aldehyde inhibitors of the proteasome reduce the accelerated proteolysis in atrophying skeletal muscles. Surg Forum 1995;46:12-5.
50. England BK, Greiber S, Mitch WE, et al. Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am J Physiol 1995;268:C1395-C1400.
51. Isozaki U, Mitch WE, England BK, Price SR. Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes require interaction between glucocorticoids and acidification. Proc Natl Acad Sci U S A 1996;93:1967-71.
52. May RC, Bailey JL, Mitch WE, Masud T, England BK. Glucocorticoids and acidosis stimulate protein and amino acid catabolism in vivo. Kidney Int 1996;49:679-83.
53. Costelli P, Carbo N, Tessitore L, et al. Tumor necrosis factor-α mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 1993;92:2783-9.
54. Zamir O, O'Brien W, Thompson R, Bloedow DC, Fischer JE, Hasselgren PO. Reduced muscle protein breakdown in septic rats following treatment with interleukin-1 receptor antagonist. Int J Biochem 1994;26:943-50.
55. Breuillc D, Farge MC, Rose F, Arnal M, Attaix D, Obled C. Pentoxifylline decreases body weight loss and muscle protein wasting characteristies of sepsis. Am J Physiol 1993;265:E660-E666.
56. Goldberg AL, Kettelhut IC, Furuno K, Fagan JM, Baracos V. Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines. J Clin Invest 1988;81:1378-83.
57. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cancer cachectic factor. Nature 1996;379:739-42.
58. Goodman MN. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 1994;205:182-5.
59. Gaczynska M, Rock KL, Spies T, Goldberg AL. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci U S A 1994;91:9213-7.
60. Tawa NE Jr, Goldberg AL. Suppression of muscle protein turnover and amino acid degradation by dietary protein deficiency. Am J Physiol 1992; 263:E317-E325.
61. May RC, Piepenbrock N, Kelly RA, Mitch WE. Leucine-induced amino acid antagonism in rats: muscle valine metabolism and growth impairment. J Nutr 1991;121:293-301.
62. Warnold I, Eden E, Lundholm K. The inefficiency of total parenteral nutrition to stimulate protein synthesis in moderately malnourished patients. Ann Surg 1988;208:143-9.
63. Ziegler TR, Gatzen C, Wilmore DW. Strategies for attenuating prorein-catabolic responses in the critically ill. Annu Rev Med 1994;45:459-80.
64. Shaw JHF, Wildbore M, Wolfe RR. Whole body protein kinetics in severely septic patients: the response to glucose infusion and total parenteral nutrition. Ann Surg 1987;205:288-94.
65. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987;27:262-6.
66. Ding H, Kopple JD, Cohen A, Hirschberg R. Recombinant human insulin-like growth factor-1 accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J Clin Invest 1993;91:2281-7.
67. Miller SB, Moulton M, O'Shea M, Hammerman MR. Effects of IGF-I on renal function in end-stage chronic renal failure. Kidney Int 1994;46: 201-7.
68. Bagatell CJ, Bremner WJ. Androgens in men - uses and abuses. N Engl J Med 1996;334:707-14.
69. Costelli P, Garcia-Martinez C, Llovera M, et al. Muscle protein waste in tumor-bearing rats is effectively antagonized by a β2-adrenergic agonist (clenbuterol): role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest 1995;95:2367-72.
70. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995;268:726-31.